课题基金 / 基金详情

项目摘要

项目成果

ELISABETH J VAN BOCKSTAELE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The noradrenergic system continues to be an important target in the development of new therapies for anxiety disorders because of its critical role in the modulation of emotional state and regulation of arousal and stress responses. Synthetic cannabinoid receptor agonists/antagonists and compounds targeting endocannabinoid synthesis/metabolism in brain have received widespread attention as these approaches may hold some therapeutic potential for psychiatric disorders. Over the prior funding period, we demonstrated that the coeruleo-cortical pathway is an important target of cannabinoid actions. We provided evidence that, under basal conditions, exposure to a synthetic cannabinoid receptor agonist increases anxiety- like behaviors that correlate with increases in multiple indices of brain noradrenergic activity. We also provided the first evidence of alterations in expression levels for several adrenergic receptor subtypes in cortical and limbic areas following acute and repeated exposure to cannabinoid receptor agonists. Finally, we established that noradrenergic transmission in limbic circuitry is critical for selected cannabinoi-induced behaviors. In the competing renewal application, circuit and cellular level studies are proposed to refine our model of how the noradrenergic system is regulated by the endocannabinoid system under conditions of stress. AIM 1 will define how molecular elements of the endocannabinoid system are positioned to impact the coeruleo-cortical pathway. AIM 2 builds on studies in AIM 1 by investigating the regulation of cortical endocannabinoid levels by noradrenergic circuitry. AIM 3 will determine if deletion of the cannabinoid type 1 receptor alters molecular and electrophysiological indices of noradrenergic activity. Finally, AIM 4 will identify stress-induced molecular and cellular adaptations in cannabinoid modulation of the coeruleo-cortical pathway. Understanding the nature of state dependent alterations of this integrative system may provide a novel substrate for the treatment of stress-induced anxiety disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of norepinephrine by cannabinoids
  • 批准号:
    8503933
  • 项目类别:
  • 资助金额:
    $34.17万
  • 财政年份:
    2005
  • 负责人:
    ELISABETH J VAN BOCKSTAELE
  • 依托单位:
Modulation of norepinephrine by cannabinoids
  • 批准号:
    8821591
  • 项目类别:
  • 资助金额:
    $45.91万
  • 财政年份:
    2005
  • 负责人:
    ELISABETH J VAN BOCKSTAELE
  • 依托单位:
Modulation of norepinephrine by cannabinoids
  • 批准号:
    7087057
  • 项目类别:
  • 资助金额:
    $26.49万
  • 财政年份:
    2005
  • 负责人:
    ELISABETH J VAN BOCKSTAELE
  • 依托单位:
Modulation of norepinephrine by cannabinoids
  • 批准号:
    7600515
  • 项目类别:
  • 资助金额:
    $32.41万
  • 财政年份:
    2005
  • 负责人:
    ELISABETH J VAN BOCKSTAELE
  • 依托单位:
海外基金